135 related articles for article (PubMed ID: 33358454)
1. [Prolactinoma causing erectile dysfunction].
Muadi J; Sánchez A
Rev Int Androl; 2021; 19(4):285-288. PubMed ID: 33358454
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Chronic LH-Testosterone Axis Suppression in Male Macroprolactinomas With Normoprolactinemia on Cabergoline.
Sehemby M; Lila AR; Sarathi V; Shah R; Sankhe S; Jaiswal SK; Ramteke-Jadhav S; Patil V; Shah N; Bandgar T
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32942295
[TBL] [Abstract][Full Text] [Related]
3. [Pituitary prolactinoma with severe erectile dysfunction as the initial symptom: diagnosis and treatment of 4 cases].
Jiang T; Zheng L; Su XM; Peng JQ; Sun DC; Li QL; Zhang ZW; Wang FP; Jiang H
Zhonghua Nan Ke Xue; 2013 Feb; 19(2):141-3. PubMed ID: 23441455
[TBL] [Abstract][Full Text] [Related]
4. Recovery pattern of hypothalamo-pituitary-testicular axis in patients with macroprolactinomas after treatment with cabergoline.
Walia R; Bhansali A; Dutta P; Khandelwal N; Sialy R; Bhadada S
Indian J Med Res; 2011 Sep; 134(3):314-9. PubMed ID: 21985814
[TBL] [Abstract][Full Text] [Related]
5. Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment.
Ribeiro RS; Abucham J
Eur J Endocrinol; 2009 Jul; 161(1):163-9. PubMed ID: 19359408
[TBL] [Abstract][Full Text] [Related]
6. Hyperprolactinemia in children and adolescents and longterm follow-up results of prolactinoma cases: a single-centre experience.
Kontbay T; Şıklar Z; Özsu E; Uyanık R; Bilici E; Ceran A; Berberoğlu M
Turk J Pediatr; 2022; 64(5):892-899. PubMed ID: 36305439
[TBL] [Abstract][Full Text] [Related]
7. Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy.
Buvat J; Lemaire A
J Urol; 1997 Nov; 158(5):1764-7. PubMed ID: 9334596
[TBL] [Abstract][Full Text] [Related]
8. Hyperprolactinaemia due to hypothalamic-pituitary disease or drug-induced in patients with erectile dysfunction.
Venetikou MS; Lambou T; Gizani D
Andrologia; 2008 Aug; 40(4):240-4. PubMed ID: 18727734
[TBL] [Abstract][Full Text] [Related]
9. What causes a prolactinoma to be aggressive or to become a pituitary carcinoma?
Phillips J; East HE; French SE; Melcescu E; Hamilton RD; Nicholas WC; Fratkin JF; Parent AD; Luzardo G; Koch CA
Hormones (Athens); 2012; 11(4):477-82. PubMed ID: 23422771
[TBL] [Abstract][Full Text] [Related]
10. Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function.
Sibal L; Ugwu P; Kendall-Taylor P; Ball SG; James RA; Pearce SH; Hall K; Quinton R
Pituitary; 2002; 5(4):243-6. PubMed ID: 14558672
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and drug therapy of prolactinoma.
Ciccarelli E; Camanni F
Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
[TBL] [Abstract][Full Text] [Related]
12. [Expression of nNOS and ultrastructural changes in the penile tissue of rats with prolactinoma-induced erectile dysfunction].
Weng BW; Hou SC; Zhu H; Xu L; Luan X; Qi HY; Wang WM; Liu W; Sun LJ
Zhonghua Nan Ke Xue; 2015 Oct; 21(10):871-6. PubMed ID: 26665672
[TBL] [Abstract][Full Text] [Related]
13. Hyperprolactinemia diagnosis in elderly men: a cohort of 28 patients over 65 years.
Shimon I; Hirsch D; Tsvetov G; Robenshtok E; Akirov A; Fraenkel M; Eizenberg Y; Herzberg D; Barzilay-Yoseph L; Livner A; Friedrich I; Manisterski Y; Ishay A; Yoel U; Masri H
Endocrine; 2019 Sep; 65(3):656-661. PubMed ID: 31154607
[TBL] [Abstract][Full Text] [Related]
14. Giant prolactinomas in men: efficacy of cabergoline treatment.
Corsello SM; Ubertini G; Altomare M; Lovicu RM; Migneco MG; Rota CA; Colosimo C
Clin Endocrinol (Oxf); 2003 May; 58(5):662-70. PubMed ID: 12699451
[TBL] [Abstract][Full Text] [Related]
15. [Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction].
López Cubillana P; Hita Rosino E; Asensio Egea L; Rigabert Montiel M; Hita Villaplana G; Server Pastor G; Server Falgás G
Arch Esp Urol; 1997 Jun; 50(5):526-8. PubMed ID: 9382597
[TBL] [Abstract][Full Text] [Related]
16. Cabergoline treatment in men with psychogenic erectile dysfunction: a randomized, double-blind, placebo-controlled study.
Nickel M; Moleda D; Loew T; Rother W; Pedrosa Gil F
Int J Impot Res; 2007; 19(1):104-7. PubMed ID: 16728967
[TBL] [Abstract][Full Text] [Related]
17. Ectopic Cavernous Sinus Microprolactinoma Treated Medically.
Minns RM; Barranco-Trabi J; Yiu AC; Hussain A; Elegino-Steffens DU
Mil Med; 2023 May; 188(5-6):1304-1306. PubMed ID: 35758408
[TBL] [Abstract][Full Text] [Related]
18. Absence of hypogonadism in a male patient with a giant prolactinoma: a clinical paradox.
Tamagno G; Daly AF; Deprez M; Vroonen L; Andris C; Martin D; Beckers A
Ann Endocrinol (Paris); 2008 Feb; 69(1):47-52. PubMed ID: 18082643
[TBL] [Abstract][Full Text] [Related]
19. Pituitary apoplexy of a giant prolactinoma during pregnancy.
Khaldi S; Saad G; Elfekih H; Ben Abdelkrim A; Ach T; Kacem M; Chaieb M; Maaroufi A; Hasni Y; Ach K
Gynecol Endocrinol; 2021 Sep; 37(9):863-866. PubMed ID: 34124989
[TBL] [Abstract][Full Text] [Related]
20. Screening for macroprolactinaemia and pituitary imaging studies.
Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]